Biospring Partners

Biospring Partners is a growth equity firm that invests in technology-enabled, EBITDA-positive B2B pharma services businesses. The firm focuses on areas including outsourced complex biomanufacturing and outsourced clinical trial services. Biospring Partners leverages deep thematic research, an experienced operating team, and a proprietary sourcing platform to support management teams with functional expertise across commercial, technical, and financial operations. The firm aims to build conviction through years of direct engagement with biopharma, providing a differentiated view into industry trends and identifying high-potential companies. Biospring Partners' investment themes include outsourced complex biomanufacturing, outsourced clinical trial services, and digital transformation. The firm has invested in companies such as Abzena, a contract development and manufacturing organization specializing in biologics and antibody drug conjugates; Cedar Health Research, a full-service outsourced clinical trial provider; ixlayer, which powers accessible and affordable health testing programs; Kiniciti, which empowers biopharmaceutical companies to develop and manufacture cell and gene therapy medicines; Labviva, a platform connecting researchers with suppliers of reagents, chemicals, and instrumentation; and PathAI, which improves diagnosis for clinical trials using an AI-based pathology platform. Biospring Partners closed its debut fund with over $245 million in capital commitments from pension plans, fund of funds, endowments and foundations, and family offices. The firm is co-founded and led by Michelle Dipp, M.D., Ph.D., and Jennifer Lum, who bring decades of experience in life sciences and technology to the firm. They aim to partner with life sciences technology companies that have the potential to fundamentally change how we research, diagnose, and treat disease. The firm's headquarters are located at 50 W 57th St, 7th Floor, New York, NY 10019, United States. For inquiries, they can be contacted via email at biospringpartners@biospring.com.